Sinovac Biotech (SVA) Posts Breakeven Q3 Loss
Tweet
Share
E-mailGet Alerts SVA Hot Sheet
Join SI Premium – FREE
Sinovac Biotech (NASDAQ: SVA) reported Q3 EPS of $0.00, versus $0.04 reported last year. Revenue for the quarter came in at $17.1 million, versus $22.1 million reported last year.
For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
